| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | -0.09 | 0.1 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.2 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | 0.058 | 0.2 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.08 | 0.2 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | 0.055 | 0.2 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.059 | 0.2 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.2 |